-
Signature
-
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
-
Stock symbol
-
RNA
-
Transactions as of
-
Jun 12, 2024
-
Transactions value $
-
-$2,803,701
-
Form type
-
4
-
Date filed
-
6/14/2024, 07:07 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RNA |
Common Stock |
Options Exercise |
$919K |
+104K |
+236.42% |
$8.82 |
148K |
Jun 12, 2024 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$3.72M |
-104K |
-70.28% |
$35.72 |
44.1K |
Jun 12, 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-104K |
-61.53% |
$0.00 |
65.2K |
Jun 12, 2024 |
Common Stock |
104K |
$8.82 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: